2BB score and signals
Stoke Therapeutics, Inc.’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 69 | High |
| Momentum | 43 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 39 | Low |
Company facts
| Headquarters | Bedford, Massachusetts, United States |
| Founded | 2014 |
| Employees | 170 |
| 52-week range | $13.17 – $40.22 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.9471 | — | $7.85M |
| 2026-08-10 | — | -0.8112 | — | $6.17M |
| 2026-05-07 | -0.79 | -0.8435 | $6.23M | $6.00M |
| 2026-03-11 | — | -0.7234 | — | $6.04M |
Related companies
